Winning in Rx Licensing
Recent evidence suggests that the fastest growing companies are often among the best at licensing. Best practice companies have created a systematic licensing process running from deal sourcing through post-deal integration, rather than depending on the efforts of a few key licensing people.
You may also be interested in...
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
BeiGene gets a new chief business executive and there are new CMOs at Cellectar Biopharma, MacroGenics and Reata Pharmaceuticals.
A new EU pilot will help drug regulators and policymakers understand the factors influencing the uneven availability of centrally authorized medicines in the member states.